Anionic Lipid, pH‐Sensitive Liposome‐Gold Nanoparticle Hybrids for Gene Delivery – Quantitative Research of the Mechanism
Source abstract
Abstract
Gene therapy is a potential method for treating a large range of diseases. Gene vectors are widely used in gene therapy for promoting the gene delivery efficiency to the target cells. Here, gold nanoparticles (AuNPs) coated with dimethyldioctadecylammonium bromide (DODAB)/dioleoylphosphatidylethanolamine (DOPE) are synthesized using a facile method for a new gene vector (DODAB/DOPE‐AuNPs), which possess 3‐ and 1.5‐fold higher transfection efficiency than those of DODAB‐AuNPs and a commercial transfection agent, respectively. Meanwhile, it is nontoxic with concentrations required for effective gene delivery. Imaging and quantification studies of cellular uptake reveal that DOPE increases gene copies in cells, which may be attributed to the smaller size of AuNPs/DNA complexes. The dissociation efficiency of DNA from the endocytic pathway is quantified by incubating with different buffers and investigated directly in the cells. The results suggest that DOPE increases the internalization of AuNPs/DNA complexes and promotes DNA release from early endosomes for the vector is sensitive to the anionic lipid membrane and the decreasing pH along the endocytic pathway. The new vector contains the potential to be the new alternative as gene delivery vector for biomedical applications.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques · Lipid Membrane Structure and Behavior
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
State Key Laboratory of Electroanalytical Chemistry Changchun Institute of Applied Chemistry Changchun Jilin 130022 China
University of Chinese Academy of Sciences Beijing 100039 China
College of Physics Jilin University Changchun Jilin 130012 China
WangDepartment of Chemistry and Physics State University of New York at Stony Brook Stony Brook New York 11794–3400 USA
References (54)
Show source-provided references
1. 10.1038/sj.gt.330048410.1038/sj.gt.3300484 ↗
2. 10.1038/nature0145110.1038/nature01451 ↗
3. 10.1016/j.bbamem.2012.10.01710.1016/j.bbamem.2012.10.017 ↗
4. 10.1042/bj2003125310.1042/bj20031253 ↗
5. 10.1038/nmat152410.1038/nmat1524 ↗
6. 10.1021/bi971772j10.1021/bi971772j ↗
7. 10.1002/anie.20120392010.1002/anie.201203920 ↗
8. 10.1002/anie.20070303910.1002/anie.200703039 ↗
9. 10.1038/sj.gt.330294010.1038/sj.gt.3302940 ↗
10. 10.1038/8332410.1038/83324 ↗
11. 10.1038/nrg214110.1038/nrg2141 ↗
12. 10.2165/00003495-200060020-0000210.2165/00003495-200060020-00002 ↗
13. 10.1038/nrg106610.1038/nrg1066 ↗
14. 10.1038/7188910.1038/71889 ↗
15. 10.1021/nn800507t10.1021/nn800507t ↗
16. 10.1002/smll.20120248510.1002/smll.201202485 ↗
17. 10.1073/pnas.111842510910.1073/pnas.1118425109 ↗
18. 10.1021/bi971772j10.1021/bi971772j ↗
19. 10.1038/337387a010.1038/337387a0 ↗
20. Xiong F. · Pharmacy · 2011 · 66 · 158
21. 10.1002/(SICI)1521-3773(19980803)37:13/14<1768::AID-ANIE1768>3.0.CO;2-410.1002/(SICI)1521-3773(19980803)37:13/14<1768::AID-ANIE1768>3.0.CO;2-4 ↗
22. 10.1023/A:100889931372210.1023/A:1008899313722 ↗
23. 10.1016/j.biomaterials.2008.05.02010.1016/j.biomaterials.2008.05.020 ↗
24. 10.1016/j.ymthe.2006.03.01010.1016/j.ymthe.2006.03.010 ↗
25. 10.1021/nn800056510.1021/nn8000565 ↗
26. 10.1016/j.biomaterials.2010.12.04310.1016/j.biomaterials.2010.12.043 ↗
27. 10.1126/science.112555910.1126/science.1125559 ↗
28. 10.1021/ja057018010.1021/ja0570180 ↗
29. 10.1021/bi960201910.1021/bi9602019 ↗
30. 10.1016/S0006-3495(96)79309-810.1016/S0006-3495(96)79309-8 ↗
31. 10.1016/j.jconrel.2006.06.02410.1016/j.jconrel.2006.06.024 ↗
32. 10.1021/la051863e10.1021/la051863e ↗
33. 10.1016/j.ijpharm.2007.04.03510.1016/j.ijpharm.2007.04.035 ↗
34. 10.1016/j.colsurfb.2006.09.01110.1016/j.colsurfb.2006.09.011 ↗
35. 10.1016/0003-2697(88)90505-210.1016/0003-2697(88)90505-2 ↗
36. 10.1016/j.biomaterials.2008.11.03710.1016/j.biomaterials.2008.11.037 ↗
37. 10.1021/jp984796o10.1021/jp984796o ↗
38. 10.1021/la052822l10.1021/la052822l ↗
39. 10.1016/j.bbamem.2004.04.00310.1016/j.bbamem.2004.04.003 ↗
40. 10.1021/bc300214z10.1021/bc300214z ↗
41. 10.1021/bc100386a10.1021/bc100386a ↗
42. 10.1016/S0006-3495(00)76396-X10.1016/S0006-3495(00)76396-X ↗
43. 10.1016/j.jconrel.2010.01.02210.1016/j.jconrel.2010.01.022 ↗
44. 10.1146/annurev.biochem.78.081307.11054010.1146/annurev.biochem.78.081307.110540 ↗
45. 10.1088/0953-8984/24/16/16420710.1088/0953-8984/24/16/164207 ↗
46. 10.1083/jcb.108.2.38910.1083/jcb.108.2.389 ↗
47. 10.1016/S0006-3495(03)70055-110.1016/S0006-3495(03)70055-1 ↗
48. 10.1016/j.cccn.2005.05.04210.1016/j.cccn.2005.05.042 ↗
49. 10.1002/anie.20060021410.1002/anie.200600214 ↗
50. 10.1023/A:101583682967010.1023/A:1015836829670 ↗
51. 10.1038/nrm88310.1038/nrm883 ↗
52. 10.1016/S0006-3495(00)76397-110.1016/S0006-3495(00)76397-1 ↗
53. 10.1021/ja306854d10.1021/ja306854d ↗
54. 10.1016/j.biomaterials.2012.10.04310.1016/j.biomaterials.2012.10.043 ↗